• COVID VACCINEGround-Breaking Study Reveals How COVID-19 Vaccines Prevent Severe Disease

    A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

  • PUBLIC HEALTHAs States Loosen Childhood Vaccine Requirements, Health Experts’ Worries Grow

    By Shalina Chatlani

    Vaccines protect not only the patient, but also those around them. Science has shown that a population can reach community immunity, also known as herd immunity, once a certain percentage of the group is vaccinated. That herd immunity can protect people who can’t get vaccinated, such as those with weakened immune systems or serious allergies, by reducing their chances of infection. But vaccine mandate opponents say it is not about science, but about their individual freedoms.

  • PUBLIC HEALTHOregon Data: COVID Vaccines Not Tied to Sudden Cardiac Death in Young People

    By Mary Van Beusekom

    A review of death certificates of previously healthy Oregon residents aged 16 to 30 years who died of cardiac or undetermined causes from June 2021 to December 2022 found no link between mRNA COVID-19 vaccination and sudden cardiac death.

  • MISINFORMATIONThe ‘Truther Playbook’: Tactics That Explain Vaccine Conspiracy Theorist RFK Jr’s Presidential Momentum

    By Stephanie Alice Baker, Chris Rojek, and Eugene McLaughlin

    Polls show that Robert Kennedy’s Jr., promoting anti-vaccine conspiracy theories, has been drawing surprising early support in his campaign for the Democratic presidential nomination. Kennedy is using the “truther playbook” - – promising identity and belonging, revealing “true” knowledge, providing meaning and purpose, and promising leadership and guidance – which prove to be appealing in our current post-truth era, in which opinions often triumph over facts, and in which charlatans can achieve authority by framing their opponents as corrupt and evil and claiming to expose this corruption. These rhetorical techniques can be used to promote populist politics just as much as anti-vaccine content.

  • PULIC HEALTHPfizer COVID Vaccine Tracking Confirms Safety in Kids, with Myocarditis, Pericarditis Rare

    By Mary Van Beusekom

    Monitoring of Pfizer/BioNTech COVID-19 vaccine safety among more than 3 million US children aged 5 to 17 years flagged just 2 of 20 health outcomes among 12- to 17-year-olds—myocarditis and pericarditis, which were rare.

  • ENERGY SECUEITYArtificial Intelligence Could Secure the Power Supply

    By Katrine Sele

    The future European power system – based primarily on renewable energy sources – will be much more weather dependent than the power system today. The two researchers believe that consumption patterns will also change. All these factors contribute to creating uncertainty around the energy supply, causing decision-making to be far more complicated.

  • VACCINATIONVaccine Could Improve Herd Immunity Around the World

    By Emily Moskal

    A low-cost, protein-based COVID-19 vaccine tested in rhesus monkeys offered immunity against known variants for at least one year. Researchers hope the vaccine, which can remain unrefrigerated for up to two weeks and may be especially beneficial for infants, will help alleviate the need for boosters while improving herd immunity around the world.

  • COVID THERAPIESThe WHO Has Advised Against the Use of Two Antibody Therapies Against COVID – Here’s What That Means

    By Zania Stamataki

    New guidance from WHO strongly advises against using the antibody therapies sotrovimab and casirivimab-imdevimab to treat patients with COVID-19. This means that, at least for the time being, there are no recommended antibody therapies to treat COVID. There are, however, still other treatment options.

  • PUBLIC HEALTHCurrent Vaccine Approach Is Not Enough to Eradicate Measles

    Current vaccination strategies are unlikely to eliminate measles. Despite marked reductions in the number of new measles and rubella cases worldwide, gaps remain between current levels of transmission and disease elimination.

  • BIOTHREATSDeveloping New Vaccine Against Three Biothreat Pathogens

    Scientists are seeking to develop a multi-pathogen vaccine that will protect against three bacterial biothreat pathogens.

  • VACCINATIONTrump’s Vaccine Endorsement Moves the Needle on COVID-19 Vaccines

    A team of economists and political scientists that included Stanford’s Brad Larsen ran a large-scale advertising experiment in thousands of U.S. counties showing a video compilation of former President Donald Trump’s Fox News interview recommending the COVID-19 vaccine, leading to a significant increase in vaccinations.

  • COVID VACCINESCOVID Vaccines Offer Lasting Protection against Reinfection: Studies

    By Mary Van Beusekom

    Two new studies suggest good, durable protection of COVID-19 vaccines against recurrent infection. NEJM editor-in-chief said that COVID-19 survivors can still benefit from subsequent vaccination, although the ideal time to vaccinate is yet unknown: “There is an advantage, and although the absolute risk difference may be small, it’s real. Also, there doesn’t appear to be a safety issue with getting boosted.”

  • PUBLIC HEALTHAntimicrobial Resistance Far Deadlier Than Thought

    By Chris Dall

    In the largest and most comprehensive study to date on the global burden of antimicrobial resistance (AMR), an international team of researchers estimates that more than 1.2 million people died from drug-resistant infections in 2019.

  • Children & COVID-19 VaccinationCovid Is Less Risky to Children than Covid Vaccines

    We should be careful about vaccinating children against the COVID-19 because it is likely that more children will die from the effects of the vaccine than from Covid itself.

  • Children & COVID-19 VaccinationCOVID: Will the U.K. Vaccinate Children Under 12?

    By Paul Hunter

    The U.K. Joint Committee on Vaccinations and Immunizations (JCVI) will help decide whether the U.K. should follow other countries – the U.S., Israel – in offering COVID-1 vaccines to all children aged five and over. When the JCVI weighed up vaccinating the next youngest age group – 12-to-15-year-olds – it found that the benefits were only “marginally greater than the potential known harms.” So marginal, in fact, that it advised against offering vaccines to this group. So, for the JCVI to give the green light to vaccinating over-fives, the health benefits will need to be more compelling than for 12-to-15-year-olds. But what does the evidence say?